Skip to main content

Malignant Hyperthermia

  • Chapter
  • First Online:
Consults in Obstetric Anesthesiology

Abstract

Malignant hyperthermia is a hypermetabolic crisis of unregulated calcium accumulation and muscle activation in response to halogenated volatile anesthetics and succinylcholine. It is most frequently caused by mutations in the ryanodine receptor, a calcium channel in the sarcoplasmic reticulum of myocytes. Symptoms include masseter muscle spasm, generalized muscle rigidity, hypercarbia, a mixed metabolic and respiratory acidosis, hyperthermia, hyperkalemia, rhabdomyolysis, myoglobinuria, arrhythmias, and cardiovascular collapse. Management consists of dantrolene, supportive care, and avoidance of triggers. The gold standard test is the caffeine halothane contracture test. Genetic testing is possible, but not all mutations are known. Parturients who are susceptible to MH or whose fetuses may be susceptible to MH should receive regional anesthesia or non-triggering anesthetics if general anesthesia is required.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rosenberg H, Davis M, James D, Stowell K. Malignant hyperthermia. Orphanet J Rare Dis. 2007;2:21.

    Article  Google Scholar 

  2. Hopkins PM. Malignant hyperthermia: pharmacology of triggering. Br J Anesth. 2011;107(1):48–56.

    Article  CAS  Google Scholar 

  3. Larach MG, Gronert GA, Allen GC, Brandom BW, Lehman EB. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006. Anesth Analg. 2010;110(2):498–507.

    Article  Google Scholar 

  4. Baum VC, O’Flaherty JE. Anesthesia for genetic, metabolic, and dysmorphic syndromes of childhood. 3rd ed. Philadelphia, PA: Wolters Kluwer; 2015.

    Google Scholar 

  5. Davies AO. Malignant temperature probe. Can Anaesth Soc J. 1980;27(2):179–80.

    Article  CAS  Google Scholar 

  6. Hughes WA, Hughes SC. Hemodynamic effects of prostaglandin E2. Obstet Anesth Dig. 1989;9(3):713–6.

    Google Scholar 

  7. Larach MG, Localio AR, Allen GC, Denborough MA, Ellis FR, Gronert GA, et al. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology. 1994;80(4):771–9.

    Article  CAS  Google Scholar 

  8. Preparing the anesthesia machine for MHS patients [Internet]. Malignant Hyperthermia Association of the United States. http://www.mhaus.org/healthcare-professionals/be-prepared/preparing-the-anesthesia-machine. Accessed 4 Jun 2016.

  9. Foster RN, Boothroyd KP. Cesarean section in a complicated case of central core disease. Anaesthesia. 2008;63(5):544–7.

    Article  CAS  Google Scholar 

  10. Hofer IS, Mahoney B, Rebarber A, Beilin Y. An ex utero intrapartum treatment procedure in a patient with a family history of malignant hyperthermia. Int J Obstet Anesth. 2014;22(2):146–8.

    Article  Google Scholar 

  11. Sewall K, Flowerdew RMM, Bromberger P. Severe muscular rigidity at birth: malignant hyperthermia syndrome? Can Anaesth Soc J. 1980;27(3):279–82.

    Article  CAS  Google Scholar 

  12. Hersch PE, Matheson KH. Anaesthetic considerations for a possible malignant hyperthermia susceptible fetus. Anaesthesia. 1996;51(1):99.

    Article  CAS  Google Scholar 

  13. Parturient with MHS partner [Internet]. Malignant Hyperthermia Association of the United States. 2009. http://www.mhaus.org/healthcare-professionals/mhaus-recommendations/parturient-with-mhs-partner. Accessed 4 Jun 2016

  14. Nanson JK, Sheikh A. Anaesthesia for emergency caesarean section in a parturient with bleeding placenta praevia and a potentially malignant hyperthermia-susceptible fetus. Int J Obstet Anesth. 2000;9(4):276–8.

    Article  CAS  Google Scholar 

  15. Girard T, Jöhr M, Schaefer C, Urwyler A. Perinatal diagnosis of malignant hyperthermia susceptibility. Anaesthesiology. 2006;104:1353–4.

    Article  Google Scholar 

  16. Stowell K, Pollock N, Langton E. Parinatal diagnosis of malignant hyperthermia susceptibility. Anaesth Intensive Care. 2007;35(3):454–5.

    CAS  PubMed  Google Scholar 

  17. Krause T, Gerbershagen MU, Fiege M, Weißhorn R, Wappler F. Dantrolene – a review of its pharmacology, therapeutic use and new developments. Anaesthesia. 2004;59(4):364–73.

    Article  CAS  Google Scholar 

  18. Shin YK, Kim YD, Collea JV, Belcher MD. Effect of dantrolene sodium on contractility of isolated human uterine muscle. Int J Obstet Anesth. 1995;4(4):197–200.

    Article  CAS  Google Scholar 

  19. Emergency treatment of an acute MH event [Internet]. Malignant Hyperthermia Association of the United States. http://www.mhaus.org/healthcare-professionals/managing-a-crisis. Accessed 4 Jun 2016.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Suzanne K. W. Mankowitz M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Menshenina, J.R., Mankowitz, S.K.W. (2018). Malignant Hyperthermia. In: Mankowitz, S. (eds) Consults in Obstetric Anesthesiology. Springer, Cham. https://doi.org/10.1007/978-3-319-59680-8_100

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-59680-8_100

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-59679-2

  • Online ISBN: 978-3-319-59680-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics